JP2000512996A - 皮膚感作および刺激の予防および治療措置 - Google Patents

皮膚感作および刺激の予防および治療措置

Info

Publication number
JP2000512996A
JP2000512996A JP10503010A JP50301098A JP2000512996A JP 2000512996 A JP2000512996 A JP 2000512996A JP 10503010 A JP10503010 A JP 10503010A JP 50301098 A JP50301098 A JP 50301098A JP 2000512996 A JP2000512996 A JP 2000512996A
Authority
JP
Japan
Prior art keywords
skin
substance
preventing
agent
phenoxyacetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP10503010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000512996A5 (enExample
Inventor
ウィル，ジョン・ジェイ
Original Assignee
ブリストル―マイヤーズ・スクイブ・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリストル―マイヤーズ・スクイブ・カンパニー filed Critical ブリストル―マイヤーズ・スクイブ・カンパニー
Publication of JP2000512996A publication Critical patent/JP2000512996A/ja
Publication of JP2000512996A5 publication Critical patent/JP2000512996A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP10503010A 1996-06-21 1997-06-17 皮膚感作および刺激の予防および治療措置 Withdrawn JP2000512996A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/670,201 US5716987A (en) 1996-06-21 1996-06-21 Prophylactic and therapeutic treatment of skin sensitization and irritation
US08/670,201 1996-06-21
PCT/US1997/009318 WO1997048369A2 (en) 1996-06-21 1997-06-17 Prophylactic and therapeutic treatment of skin sensitization and irritation

Publications (2)

Publication Number Publication Date
JP2000512996A true JP2000512996A (ja) 2000-10-03
JP2000512996A5 JP2000512996A5 (enExample) 2004-11-25

Family

ID=24689424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10503010A Withdrawn JP2000512996A (ja) 1996-06-21 1997-06-17 皮膚感作および刺激の予防および治療措置

Country Status (7)

Country Link
US (2) US5716987A (enExample)
EP (1) EP0954300A4 (enExample)
JP (1) JP2000512996A (enExample)
AU (1) AU716125B2 (enExample)
CA (1) CA2258736A1 (enExample)
NZ (1) NZ333324A (enExample)
WO (1) WO1997048369A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605642B2 (en) 1999-04-05 2003-08-12 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGES)
US7030133B2 (en) * 1999-04-05 2006-04-18 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6337350B1 (en) 1999-04-05 2002-01-08 City Of Hope Inhibitors of formation of advanced glycation endproducts (AGEs)
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7576131B2 (en) 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
AU1773601A (en) * 1999-11-18 2001-05-30 John D. Bolla Treatment or prevention of photoaging and skin cancer
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
AU2004287434B2 (en) * 2003-10-27 2011-04-07 City Of Hope Methods of lowering lipid levels in a mammal
CA2567437A1 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020102695A1 (en) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Thermally regulated transdermal drug delivery system
US11865602B2 (en) * 2020-01-16 2024-01-09 Ehc Inc. Paintless dent removal tool, system and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383662A1 (fr) * 1977-03-15 1978-10-13 Cassenne Lab Sa Nouvelles compositions a usage cosmetique
JPS55133304A (en) * 1979-04-05 1980-10-17 Shiseido Co Ltd Perfume controller
US4524214A (en) * 1983-11-03 1985-06-18 Stauffer Chemical Company Process for forming esters of glyoxylic acids
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
DE4225794C2 (de) * 1992-07-31 1994-12-08 Schuelke & Mayr Gmbh Tb-wirksame Carbonsäuren

Also Published As

Publication number Publication date
US6670395B1 (en) 2003-12-30
NZ333324A (en) 2000-08-25
EP0954300A2 (en) 1999-11-10
US5716987A (en) 1998-02-10
EP0954300A4 (en) 2004-10-20
WO1997048369A2 (en) 1997-12-24
AU3372797A (en) 1998-01-07
CA2258736A1 (en) 1997-12-24
AU716125B2 (en) 2000-02-17
WO1997048369A3 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
JP2000512996A (ja) 皮膚感作および刺激の予防および治療措置
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
JP2953625B2 (ja) 薬剤／浸透促進組成物に関連する皮膚刺激を低下させる方法
Mehta Topical and transdermal drug delivery: what a pharmacist needs to know
KR20110017365A (ko) 피부 염증 및 변색을 위한 방법 및 조성물
MXPA97003694A (en) Profilactico and therapeutic treatment of the sensitization and irritation of the p
CA2361407A1 (en) Pharmaceutical compositions
JPH10512851A (ja) 皮膚感作および刺激の予防および治療処置
JPH04210914A (ja) 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法
MXPA97003693A (en) Profilactic treatment of allergic dermatitis by conta
JPH11502513A (ja) 糖尿病性ニューロパシーの処置方法
JPH09110680A (ja) 皮膚炎治療貼付剤
CN112891242A (zh) 一种用于祛斑美白抗炎的组合物及其应用
JPH03227921A (ja) ケロイド治療剤
US20200360317A1 (en) Carboxylic acids for treating/preventing a skin disease
JP2002356430A (ja) 吉草酸酢酸プレドニゾロン及び抗ヒスタミン剤を含む皮膚外用剤
JPH1180031A (ja) 外用剤及び経皮又は経粘膜吸収性を増進する方法
RU2426540C1 (ru) Противовоспалительное и противоаллергическое лекарственное средство и фармацевтическая композиция на его основе
JPH0971539A (ja) 外用鎮痒剤
KR20190008236A (ko) 소아기 적용을 위한 카르복실산
Zimmerman New Therapeutic Agent for Tinea Versicolor: 9-Aminoacridinium 4-Hexylresorcinolate
HK40002520A (en) Carboxylic acids for treating/preventing a skin disease
JP2013501735A (ja) セチリジン塩酸塩の薬剤溶液

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040210

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20061201

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20061201